Jonas Pielenhofer

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Venues

Pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus Philipp Radsak, Hilde Spahn-Langguth, Peter Langguth
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics 15 (2) (2023)
Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus Philipp Radsak, Hilde Spahn-Langguth, Peter Langguth
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics 15 (2) (2023)
Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus Philipp Radsak, Hilde Spahn-Langguth, Peter Langguth
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics 15 (2) (2023)
Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus Philipp Radsak, Hilde Spahn-Langguth, Peter Langguth
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics 15 (2) (2023)

Jonas Pielenhofer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jonas Pielenhofer